These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 26536599)
1. Survival of Hepatitis C Virus in Syringes Is Dependent on the Design of the Syringe-Needle and Dead Space Volume. Binka M; Paintsil E; Patel A; Lindenbach BD; Heimer R PLoS One; 2015; 10(11):e0139737. PubMed ID: 26536599 [TBL] [Abstract][Full Text] [Related]
2. Recovering Infectious HIV from Novel Syringe-Needle Combinations with Low Dead Space Volumes. Abdala N; Patel A; Heimer R AIDS Res Hum Retroviruses; 2016; 32(10-11):947-954. PubMed ID: 27548374 [TBL] [Abstract][Full Text] [Related]
3. Disinfection of syringes contaminated with hepatitis C virus by rinsing with household products. Binka M; Paintsil E; Patel A; Lindenbach BD; Heimer R Open Forum Infect Dis; 2015 Jan; 2(1):ofv017. PubMed ID: 26034767 [TBL] [Abstract][Full Text] [Related]
4. Options for reducing HIV transmission related to the dead space in needles and syringes. Zule WA; Pande PG; Otiashvili D; Bobashev GV; Friedman SR; Gyarmathy VA; Des Jarlais DC Harm Reduct J; 2018 Jan; 15(1):3. PubMed ID: 29334973 [TBL] [Abstract][Full Text] [Related]
5. Detachable low dead space syringes for the prevention of hepatitis C among people who inject drugs in Bristol, UK: an economic evaluation. Hancock E; Ward Z; Ayres R; Neale J; Hussey D; Kesten JM; Hickman M; Vickerman P Addiction; 2020 Apr; 115(4):702-713. PubMed ID: 31633849 [TBL] [Abstract][Full Text] [Related]
6. Factors that influence the characteristics of needles and syringes used by people who inject drugs in Tajikistan. Zule WA; Latypov A; Otiashvili D; Kirtadze I; Ibragimov U; Bobashev GV Harm Reduct J; 2015 Oct; 12():37. PubMed ID: 26472669 [TBL] [Abstract][Full Text] [Related]
7. Recovery of Infectious Hepatitis C Virus From Injection Paraphernalia: Implications for Prevention Programs Serving People Who Inject Drugs. Heimer R; Binka M; Koester S; Grund JC; Patel A; Paintsil E; Lindenbach BD J Infect Dis; 2018 Jan; 217(3):466-473. PubMed ID: 28968665 [TBL] [Abstract][Full Text] [Related]
8. Feasibility of needle and syringe programs in Tajikistan distributing low dead space needles. Zule WA; Latypov A; Otiashvili D; Bangel S; Bobashev GV Harm Reduct J; 2018 Aug; 15(1):44. PubMed ID: 30170604 [TBL] [Abstract][Full Text] [Related]
9. Usage of low dead space syringes and association with hepatitis C prevalence amongst people who inject drugs in the UK. Trickey A; May MT; Hope V; Ward Z; Desai M; Heinsbroek E; Hickman M; Vickerman P Drug Alcohol Depend; 2018 Nov; 192():118-124. PubMed ID: 30245460 [TBL] [Abstract][Full Text] [Related]
10. Variation in syringes and needles dead space compared to the International Organization for Standardization standard 7886-1:2018. Cambruzzi M; Macfarlane P Vet Anaesth Analg; 2021 Jul; 48(4):532-536. PubMed ID: 34059461 [TBL] [Abstract][Full Text] [Related]
11. The Effectiveness of Low Dead Space Syringes for Reducing the Risk of Hepatitis C Virus Acquisition Among People Who Inject Drugs: Findings From a National Survey in England, Wales, and Northern Ireland. Trickey A; Croxford S; Emanuel E; Ijaz S; Hickman M; Kesten J; Thomas C; Edmundson C; Desai M; Vickerman P Clin Infect Dis; 2022 Sep; 75(6):1073-1077. PubMed ID: 35184173 [TBL] [Abstract][Full Text] [Related]
12. Survival of hepatitis C virus in syringes: implication for transmission among injection drug users. Paintsil E; He H; Peters C; Lindenbach BD; Heimer R J Infect Dis; 2010 Oct; 202(7):984-90. PubMed ID: 20726768 [TBL] [Abstract][Full Text] [Related]
13. Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug users. Major M; Gutfraind A; Shekhtman L; Cui Q; Kachko A; Cotler SJ; Hajarizadeh B; Sacks-Davis R; Page K; Boodram B; Dahari H Sci Transl Med; 2018 Jul; 10(449):. PubMed ID: 29997251 [TBL] [Abstract][Full Text] [Related]
14. Estimating the number of people who inject drugs and syringe coverage in Australia, 2005-2016. Kwon JA; Iversen J; Law M; Dolan K; Wand H; Maher L Drug Alcohol Depend; 2019 Apr; 197():108-114. PubMed ID: 30802734 [TBL] [Abstract][Full Text] [Related]
15. Co-design of harm reduction materials for people who inject drugs to implement research findings. Hussey D; Trinder-Widdess Z; Dee C; Bagnall D; Bojangles T; Kesten JM Harm Reduct J; 2019 Jun; 16(1):36. PubMed ID: 31174536 [TBL] [Abstract][Full Text] [Related]
16. Acceptability of low dead space syringes and implications for their introduction: A qualitative study in the West of England. Kesten JM; Ayres R; Neale J; Clark J; Vickerman P; Hickman M; Redwood S Int J Drug Policy; 2017 Jan; 39():99-108. PubMed ID: 27788406 [TBL] [Abstract][Full Text] [Related]
17. Social marketing of low dead space syringes in Vietnam: findings from a 1-year pilot program in Hanoi, Thai Nguyen, and Ho Chi Minh City. Huong NT; Mundy G; Neukom J; Zule W; Tuan NM; Tam NM Harm Reduct J; 2015 May; 12():15. PubMed ID: 26024921 [TBL] [Abstract][Full Text] [Related]
18. Quantification of COVID-19 Vaccine Needle and Syringe Dead Space Volumes. Smith DM; Weiss SL; White KM Cureus; 2021 Oct; 13(10):e18969. PubMed ID: 34812330 [TBL] [Abstract][Full Text] [Related]
19. Effects of syringe material and needle size on the minimum plunger-displacement pressure of arterial blood gas syringes. Ansel GM; Douce FH Respir Care; 1982 Feb; 27(2):147-51. PubMed ID: 10315159 [TBL] [Abstract][Full Text] [Related]
20. Are major reductions in new HIV infections possible with people who inject drugs? The case for low dead-space syringes in highly affected countries. Zule WA; Cross HE; Stover J; Pretorius C Int J Drug Policy; 2013 Jan; 24(1):1-7. PubMed ID: 22884539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]